| 1/12/2017 | CV | Universal raises conversion rate on 6.75% convertible preferreds
|
| 1/9/2017 | CVLM | Universal forces conversion of 6.75% convertible perpetual preferreds
|
| 9/4/2015 | BKCVIG | S&P changes Universal to stable
|
| 5/22/2014 | CV | Market Commentary: Post rises in aftermarket after upsizing; Amyris plans $75 million deal; preferreds eyed
|
| 2/13/2014 | CV | Market Commentary: Imperial gains in modest trade; planned Akamai sees par bid; Medicines expands on hedge
|
| 1/6/2014 | BKCVHYIGPF | S&P trims Universal Corp. view to negative
|
| 10/31/2013 | BKCVHYIGPF | Fitch: Universal loan BBB-
|
| 8/12/2013 | CV | Market Commentary: Tesla down outright, better dollar neutral; Dendreon weakens; Web.com adds; Rambus on tap
|
| 8/23/2012 | BKCVHYIG | S&P lifts Universal to stable
|
| 11/23/2011 | CVHYIGPF | Universal files automatic shelf covering stock, debt and preferreds
|
| 10/27/2010 | BKCVHYIG | S&P lowers Universal outlook to negative
|
| 11/16/2009 | BKCVHY | S&P rates Universal notes BBB-
|
| 11/16/2009 | BKCVHY | Moody's gives Universal notes Ba2
|
| 2/5/2009 | CV | Universal adjusts conversion rate on 6.75% convertible preferreds
|
| 11/25/2008 | CVIG | Universal files automatic shelf registration
|
| 11/15/2007 | CVIG | Moody's: Universal view negative
|
| 11/8/2007 | CVIG | S&P: Universal unaffected
|
| 8/4/2006 | BKCV | Moody's confirms Universal
|
| 7/12/2006 | CV | S&P ups Universal outlook to stable
|
| 3/16/2006 | CV | Market Commentary: BioMarin stock hovers near strike price with call approaching; Kulicke and Soffa raises chip sector worries
|
| 3/16/2006 | CV | New Issue: Universal Corp. prices $200 million of convertible perpetual preferreds at 6.75%, up 27.5%
|
| 3/15/2006 | CV | Market Commentary: Waste Connections gains on debut; Universal ups premium in talk; CSX, PMC-Sierra gain on upgrades
|
| 3/15/2006 | CV | Universal Corp. raises premium talk to 25%-30% for planned $200 million convertible preferreds
|
| 3/14/2006 | BKCVHY | Moody's cuts Universal to junk
|
| 3/14/2006 | CV | Universal Corp. to price $200 million of convertible preferreds, talked at 6.75%-7.25%, up 20%-25%
|
| 3/14/2006 | CV | Market Commentary: Fair Isaac plunges on fears of new rival product; Human Genome slides on mixed trial results
|
